IS8231A - Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða - Google Patents

Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða

Info

Publication number
IS8231A
IS8231A IS8231A IS8231A IS8231A IS 8231 A IS8231 A IS 8231A IS 8231 A IS8231 A IS 8231A IS 8231 A IS8231 A IS 8231A IS 8231 A IS8231 A IS 8231A
Authority
IS
Iceland
Prior art keywords
carboxylic acid
acid derivatives
pharmaceutically useful
useful salts
salts
Prior art date
Application number
IS8231A
Other languages
English (en)
Inventor
Aurell Carl-Johan
Dahlström Mikael
Lindstedt-Alstermark Eva-Lotte
Minidis Anna
Ohlsson Bengt
Ståhle Erica
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS8231A publication Critical patent/IS8231A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS8231A 2003-06-18 2006-01-13 Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða IS8231A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314129.8A GB0314129D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/SE2004/000964 WO2004110984A1 (en) 2003-06-18 2004-06-16 Pharmaceutically useful salts of carboxylic acid derivates

Publications (1)

Publication Number Publication Date
IS8231A true IS8231A (is) 2006-01-13

Family

ID=27636788

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8231A IS8231A (is) 2003-06-18 2006-01-13 Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða

Country Status (23)

Country Link
US (1) US20060142389A1 (is)
EP (1) EP1638922A1 (is)
JP (1) JP3822900B1 (is)
KR (1) KR20060027348A (is)
CN (1) CN1809529A (is)
AR (1) AR044801A1 (is)
AU (1) AU2004247610B2 (is)
BR (1) BRPI0411525A (is)
CA (1) CA2528932A1 (is)
CO (1) CO5650228A2 (is)
GB (1) GB0314129D0 (is)
IL (1) IL172167A0 (is)
IS (1) IS8231A (is)
MX (1) MXPA05013714A (is)
MY (1) MY137277A (is)
NO (1) NO20055922L (is)
RU (1) RU2005138590A (is)
SA (1) SA04250169B1 (is)
TW (1) TW200503677A (is)
UA (1) UA81807C2 (is)
UY (1) UY28375A1 (is)
WO (1) WO2004110984A1 (is)
ZA (1) ZA200510252B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0229931D0 (en) * 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0314079D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
ES2299702T3 (es) 2002-06-20 2008-06-01 Astrazeneca Ab Derivados de acido benzoico orto-sustituidos para el tratamiento de la resistencia a la insulina.
SE0403072D0 (sv) * 2004-12-16 2004-12-16 Astrazeneca Ab Pharmaceutically useful salts of carboxylic acid derivates
WO2007004957A1 (en) * 2005-07-05 2007-01-11 Astrazeneca Ab Novel crystalline form
AR055073A1 (es) * 2005-07-11 2007-08-01 Astrazeneca Ab Agentes terapeuticos
NO2686520T3 (is) 2011-06-06 2018-03-17
US20120329836A1 (en) 2011-06-06 2012-12-27 The Ohio State University Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
RU2019134558A (ru) 2013-06-13 2020-02-20 Экебиа Терапьютикс, Инк. Композиции и способы лечения анемии
EP3578546A1 (en) 2013-11-15 2019-12-11 Akebia Therapeutics Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
BR112017015852A2 (pt) 2015-01-23 2018-03-27 Akebia Therapeutics Inc forma de cristal, sal hemicálcico, sal hemicálcico di-hidratado, sal monossódico hidratado, sal bissódico monoidratado, sal monossódico anidro e método para preparar o composto 1
UA123308C2 (uk) 2015-04-01 2021-03-17 Екебіа Терапьютікс, Інк. Композиції і способи для лікування анемії
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20013593A3 (cs) * 1999-04-06 2002-03-13 Sankyo Company, Limited Alfa-Substituované deriváty karboxylových kyselin
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
AU2004247610B2 (en) 2008-04-17
TW200503677A (en) 2005-02-01
CN1809529A (zh) 2006-07-26
BRPI0411525A (pt) 2006-08-01
CA2528932A1 (en) 2004-12-23
CO5650228A2 (es) 2006-06-30
SA04250169B1 (ar) 2007-08-07
JP2006527766A (ja) 2006-12-07
MY137277A (en) 2009-01-30
NO20055922L (no) 2006-01-06
GB0314129D0 (en) 2003-07-23
ZA200510252B (en) 2006-12-27
IL172167A0 (en) 2009-02-11
RU2005138590A (ru) 2006-07-27
MXPA05013714A (es) 2006-06-27
UY28375A1 (es) 2005-01-31
AR044801A1 (es) 2005-10-05
KR20060027348A (ko) 2006-03-27
JP3822900B1 (ja) 2006-09-20
WO2004110984A1 (en) 2004-12-23
US20060142389A1 (en) 2006-06-29
UA81807C2 (uk) 2008-02-11
EP1638922A1 (en) 2006-03-29
SA04250169A (ar) 2005-12-03
AU2004247610A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
CY2009011I1 (el) Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης
NO2014005I1 (no) olodaterol, syreaddisjonssalter og farmakologisk akseptable syrer derav
ATE427296T1 (de) Phenoxyessigsaurederivate
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
ATE384696T1 (de) Mandelsäure derivate
NO20050884D0 (no) Ny fremgangsmate for syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
NO20054957D0 (no) Subtituerte karboksylsyrer
NO20024387D0 (no) Karboksylsyrederivater som IP-antagonister
NO20043660L (no) Salter av valsartan
NO20054763D0 (no) Salts of clopidogrel and process for preparation
ATE410407T1 (de) Zimtsäureamidderivate
HK1073102A1 (en) Sulphonic acid salts of mandelic acid derivatives
AP2076A (en) New Heterocyclic carboxylic acid amide derivatives
NO20035694D0 (no) Nye sulfonsyrederivater
ATE384530T1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
DK1650186T3 (da) Nye dicarboxylsyrederivater
NO20053673D0 (no) Nye antikonvulsanderivatsalter
FI20020593A (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
NO20050183L (no) Farmasoytiske salter av reboxetin
EP1677781A4 (en) SALTS OF PHARMACOLOGICALLY ACTIVE COMPOUNDS
CY1105789T1 (el) Νεα μεθοδος για τη συνθεση πepιντοπριλ και των φαρμακευτικως αποδεκτων αλατων αυτου
DK1497290T3 (da) Fremgangsmåde til fremstilling af syresalte af gemifloxacin